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Abstract 
Background: Evaluation of High-sensitivity C-reactive protein, malondialdehyde(MDA)levels in type 2diabetic 
patients compare with healthy controls and correlate these levels with glycated hemoglobin (HbA1C) and insulin 
resistance.Materials and Methods: A prospective evaluation study was carried out in the Department of 
Biochemistry, Netaji Subhas Medical College and Hospital, Patna, Bihar India. The study population consisted of 
200 subjects divided in to two groups viz., diabetic patients (type 2 diabetic subjects; n=100) and non- diabetic 
participants (n=100). 100 male and 100 female were include in this study. The age of the patients of both sex were 
30-50 years. Serum hs- CRP and insulin was assessed by ELISA, malondialdehyde (MDA) was assessed by 
Thiobarbituric Acid Reactive Substances (TBARS) method and other routine investigations were carried out by 
standardized protocols with vitros 350fully automated analyzer. Results: The mean serum hs-CRP and MDA levels 
were significantly highin type 2 diabetic patients compared with healthy patients. Hs-CRP and MDA levels we are 
shown significant positive correlation with glycocylated hemoglobin (HbA1C), insulin resistance, triglycerides and 
negative correlation with HDL cholesterol. Conclusion: Elevated hs - CRP, MDA levels are potentially important 
diagnostic markers for the assessment of endothelial dysfunction in type 2 diabetic patients. Tight blood glucose 
control, regular monitoring of hs-CRP, MDA levels within normal range might be useful for reduction of vascular 
complications in type 2 diabetic patients 
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Diabetes mellitus (DM) considered as a widespread 
global disease. Conferring to recent reports, about 171 
million persons in the world with DM in the year 2000 
and this number expected to increase to 366 million 
through 2030. This disease is correlated with reducing 
life expectancy and significant other illnesses due to its 
relationship with microvascular complications 
(ischaemic heart disease, stroke and peripheral vascular 
disease), as a result led to lessen life quality[1].  
Glycated hemoglobin (HbA1c) represents the blood 
glucose average level within the past 3 months. 
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Therefore, HbA1c is a very important biochemical 
parameter that provide long term status of blood 
glucose levels and monitoring tool for measuring 
glycemic control in Type – 2 diabetic patients[2]. 
HbA1c in general, developed when the hemoglobin 
joined with glucose in the blood and become 
glycated[3].  According to many studies, HbA1c levels 
could be used as an independent risk factor for stroke 
and Cardiovascular disease (CVD) in both healthy and 
diabetics persons. It has been found that a (0.2%) 
decrease of HbA1c level can lower the risk of CVD 
development by 10%[4].  Furthermore, many studies 
have revealed, newborns moms with high HbA1c 
levels are more likely suffering from development of 
CVD in the future[5]. 
.
Chronic hyperglycemia and 
oxidative stress increases the pro-inflammatory 
proteins with infiltrated macrophages secreting 
inflammatory cytokines which leads tosystemic 
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inflammation [6]. HsC reactive protein is an acute 
phase reactant protein produced by liver response 
toseveral cytokines and sensitive marker of low grade 
systemic inflammation[7,8].  Studies reported that hs - 
CRP directly binds to oxidized low-density lipoprotein 
cholesterol(LDL- C),induces plasminogen activator 
inhibitor-1expression endothelial dysfunction by which 
leads to cardiovascular disease (CVD)[9-11]. 
Hyperglycemia  induced  oxidative  stress  induces  pro 
inflammatory reactants with infiltrated macrophages 
secreting inflammatory cytokines which leads to local 
and systemic inflammation [12]. It has been recognized 
high levels of free radicals or reactive oxygen species 
(ROS), reactive nitrogen species (RNS) directly 
damage to the lipids which leads to formation of 
aldehydes such as malondialdehyde (MDA), propanal, 
hexanal, and 4-hydroxynonenal (4- HNE)[13]. So, in 
this view the objective of present study was to evaluate 
hs -CRP, MDA levels in type 2 diabetic patients and 
also to explore their association with HbA1c and 
insulin resistance. 
 
Materials and methods 
A prospective evaluation study was carried out in the 
Department of Biochemistry, Netaji Subhas Medical 
College and Hospital ,Patna, Bihar India from 
November 2019 to April 2020, after taking the 
approval of the protocol review committee and 
institutional ethics committee. 
Study sample and inclusion/exclusion criteria 
The study population consisted of 200 subjects divided 
in to two groups viz., diabetic patients (type 2 diabetic 
subjects; n=100) and non- diabetic participants 
(n=100). 100 male and 100 female were include in this 
study. The age of the patients of both sex were 30-50 
years.We excluded the patients on insulin,smokers, 
alcoholics, tobacco chewers, renal disease, 
inflammatory disorders, neoplastic disorders, thyroid 
disorders, liver dysfunction, and history of acute 
myocardial infarction, stroke and occlusive peripheral 
vascular disease. 
Biochemical analysis 
Fasting venous blood samples were collected from the 
study subjects and centrifuged at 3000 rpm for 15 min. 
Routine laboratory investigations were carried out by 
standardized protocols with vitros 350 fully automated 
analyzer. Serum insulin estimated by Enzyme Linke d 
Immuno Sorbe nt Assay (ELISA), HbA1c estimated by 
(Ion Exchange Resin method) hs- CRP was assessed by 
(latex turbidimetric immunoassay), malondialdehyde 
(MDA) estimated by Thiobarbituric Acid Reactive 
Substances (TBARS) method[14]. Post prandial 
venous blood samples collected for plasma glucose 
(PPG) analysis. Homeostasis model assessment for 
Insulin Resistance (HOMA-IR) HOMA- IR calculated 
by using fasting glucose and insulin values: HOMA – 
IR= fasting insulin X fasting glucose (m 
M/L)/22.51[15].  
Statistical analysis  
The recorded data was compiled and entered in a 
spreadsheet computer program (Microsoft Excel 2010) 
and then exported to data editor page of SPSS version 
19 (SPSS Inc., Chicago, Illinois, USA). Descriptive 
statistics included computation of percentages and 
means. Test applied for the analysis was student t-test. 
The confidence interval and level of significance were 
set at 95% and 5%. 
 
Results  
Table 1: Gender and age distribution of patients 
Variables N=200 Percentage % 
Gender  
Male 100 50 
Female 100 50 
Age  
30-40 years 80 40 
40-50 years 120 60 
Table 2: Comparison of baseline parameters in controls, type 2 diabetic patients 
               Parameters Controls(N=100) T2DM(N=100) 
p-value 
 
Age 38.3±3.6 39.6±6.9 0.44 (NS) 
Body mass index (BMI) kg/m
2
 25.1±1.3 28.1±2.6 0.012* 
Waist/Hip ratio 0.92±0.02 0.94±0.11 0.024* 
Systolic BP(mmHg 116.3±5.7 119.2±9.4 0.08 (NS) 
Diastolic BP (mm Hg) 77.1±5 .8 80±7.8 0.13 (NS) 
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*indicates statistical significance (≤0.05) 
 
Table 3: Comparison of FPG, PPG, HbA1C, HOMA-IR, Lipid profile, Liver profile, Renal profile hs-CRP 
and MDA levels in control and type 2 diabetic subjects 
Parameters Controls (N=50) T2DM(N=50) p-value 
FPG(mg/dl) 80.9±  8.7 134.0±13.5 0.021* 
PPG(mg/dl) 106 .2±8.8 189±23 .6 0.032* 
HbA1C 5.1±0.6 8.7±0.9 0.026* 
Serum Triglycerides (mg/dl) 97.7±11.1 135.1±14.4 0.031* 
Serumcholesterol (mg/dl) 179.8±9.8 207.2±22.8 0.042* 
HOMA-IR 1.3±0.2 3.9±0.9 0.039* 
HDLcholesterol (mg/dl 44.0±1.9 40.1±3.1 0.027* 
LDLcholesterol (mg/dl) 109±11.1 135.0±14.2 0.014* 
Total Bilirubin(mg/dl 0.76±0.06 0.78±0.07 0.72 (NS) 
Direct Bilirubin(mg/dl) 0.2±0.07 0.19±0.08 0.41 (NS) 
Serumurea(mg/dl) 22.9±4.6 27.2±6.9 0.24 (NS) 
Serum creatinine(mg/dl) 0.67±0.3 0.78±0.7 0.311 (NS) 
Hs-CRP(mg/L) 1.8±0.3 4.1±1.7 0.018* 
MDA(µmol/L 1.8±0.6 5.9±1.6 0.029* 
 
Table 4: Correlation between hs-CRP &measured parameters in type 2 diabetic patients 
Parameters Correlation Coefficient(r) 
BMI 0.615** 










*Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed 
Table 5: Correlation between MDA &measured parameters in type 2 diabetic patient 
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*Correlation is significant at the 0.05 level (2-tailed). 




Oxidative stress stimulates the inflammatory mediators 
which in turn enhances the production of reactive 
oxygen species (ROS) and reactive nitrogen species 
(RNS). Oxidative stress induces tumour necrosis factor 
alpha (TNF- α) secretion, it is linked to obesity related 
insulin resistance and vascular complications in type 2 
diabetes mellitus[16,17].  Several studies explored that 
oxidative stress is not only due to free radical 
generation and also due to nonenzymatic protein 
glycosylation, auto-oxidation of glucose, impaired 
glutat hione metabolism, decreased antioxidant 
capacity[18 – 20]..  The present study has been shown 
significant increased hs- CRP and MDA levels in 
T2DM patients compared with healthy controls.Body 
mass index and (BMI) and Waist hip ratio we re-
significantly increased in T2DM patients compared 
with healthy controls and also hs-CRP, MDA showed 
significant positive correlation with BMI. Obesity is 
considered as low-grade systemic inflammation, which 
results in metabolic derangements, insulin resistance 
and eventually precedes type 2 diabetes mellitus[21]. 
Obesity enhances sympathetic drive, increase 
vasomotor tone and hypertension; they proceed to 
metabolic abnormalities such as dyslipidemia, insulin 
resistance, inflammation, endothelial dysfunction and 
organ injury[22-24].The present study also exhibits 
dyslipidemias in T2DM patients as reported earlier 
studies. High triglyceride levels and as well as 
decreased high-density lipoprotein (HDL) cholesterol, 
most likely underlying cause of increased free fatty 
acid flux,insulin resistance and vascular complications 
in type 2 diabetes mellitus[25,26]. We have observed 
significantly increased total cholesterol,triglycerides, 
LDL- C and decreased HDL-C in T2DM patients 
compared with healthy individuals and also hs -CRP, 
MDA levels were positively correlated triglycerides 
and negatively correlated with HDLcholesterol In the 
present study we observed hs - CRP levels showed 
significant positive correlation with MDA, HbA1c and 
HOMA-IR. Chronic inflammation is potentially 
unifying mechanistic cause, accompanied by activation 
of major inflammatory pathways such as JunN-
terminal kinases  and the transcription factor NF-
kappaB along with decreased HDL-cholesterol, with 
impairment  in reverse cholesterol transport mechanism 
and parallel changes in apolipoproteins, enzymes, 
decreased anti- oxidant capacity[27-29]. 
 
Decreased 
HDL-Cholesterol and phospholipids could stimulate 
accumulation of VLDL, which binds bacterial products 
and other toxic substances, resulting in 
hypertriglyceridemia.  
Furthe rmore, it promotes lipid peroxidation by 
peroxynitrite formation bydecreasing endogenous 
antioxidant defences and enhances the formation of 
atherosclerotic lesions[30].ROS and RNS are 
collectively used to   describe free radicals and other 
non-radical reactive derivatives known as oxidants.  
Biologically free radicalsare highly unstable molecules 
which are products of normal cellular metabolism. 
Oxidative stress induced DNA damage markers such as 
8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-oxo-7, 
8-dihydro-2’-deoxyguanosine; lipid-peroxidation 
products measured as thiobarbituric acid reactive 
substances (TBARS). In the present study we observed 
significantly increased MDA levels in T2DM patients 
compared to healthy controls and also positive 
correlation with HbA1c and HOMA-IR.  HbA1c is 
widely used as mean glycemic index in diabetes and 
also useful measurement for the vascular 
complications.  Oxidative stress plays a crucial role in 
pathogenesis of diabetic vascular complication[31].  
Chronic hyperglycemia in diabetic patients can 
increase production of free radicals through Amadori 
rearr angement[32]. In general, the ROS and RNS are 
continuously generated in physiological conditions and 
are eliminated by several antioxidant enzymes. 
  Co-existence of inflammation, increased lipid 
peroxidation, dyslipidemia along with hyperglycemia 
conditions could pathologically increase the effect of 
oxidative stress[33]. However, the  decreased  
efficiency of cellular antioxidant mechanisms with 
simultaneously enhanced lipid peroxidation along with 
increased insulin resistance and HbA1c may contribute 
factors of provoking inflammatory pathways and 
vascular complications in type 2 diabetes mellitus. 
 
Conclusion  
Elevated hs-CRP, MDA levels are potentially 
important diagnostic markers for the assessment of 
endothelial dysfunction in type 2 diabetic patients. 
Tight blood glucose control, regular monitoring of hs-
CRP, MDA levels within normal range might be useful 
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